Hand Sanitizer Use for Herpes Simplex Virus-1

Status unconfirmed · Early Phase 1

Conditions studied: Virus, HSV-1, Herpes Simplex 1, Herpes Simplex Labialis

In brief

The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration of an HSV-1 (herpes) lesion is the primary endpoint for this study. Size, pain, and discomfort are the secondary endpoints.

Key facts

Study ID

NCT06135844

Run by

Leciel Bono

People needed

20

Starts

2022-04-08

Expected to finish

2023-11-30

Last updated by the study team

2023-11-18

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• For the purpose of this study participants must be:
• in the early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom)
• have a visible manifestation of a lesion
• be 18 years or older
• capable of following daily treatment instructions
• willing to complete a daily journal
• willing to come to the clinic twice for records and pictures during the14 days that the lesion is present or until participant is free of lesion.

You may not qualify if…

• For the purpose of this study participants cannot:
• be immunocompromised
• be pregnant
• have taken any antiviral medication within the last two weeks
• have used any creams in the last ten days.

Where it is running

• Idaho State University — Pocatello, Idaho, United States (enrolling)
• Cotton Creek Dental — St. George, Utah, United States (enrolling)
• Utah Tech University — St. George, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.